APA (7th ed.) Citation

MG, I., A, P., E, A., RG, F., JM, L., DG, L., . . . D, D. (2024). Efficacy and Safety of Respiratory Syncytial Virus (RSV) Prefusion F Protein Vaccine (RSVPreF3 OA) in Older Adults Over 2 RSV Seasons. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 78(6), 1732. https://doi.org/10.1093/cid/ciae010

Chicago Style (17th ed.) Citation

MG, Ison, et al. "Efficacy and Safety of Respiratory Syncytial Virus (RSV) Prefusion F Protein Vaccine (RSVPreF3 OA) in Older Adults Over 2 RSV Seasons." Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America 78, no. 6 (2024): 1732. https://doi.org/10.1093/cid/ciae010.

MLA (9th ed.) Citation

MG, Ison, et al. "Efficacy and Safety of Respiratory Syncytial Virus (RSV) Prefusion F Protein Vaccine (RSVPreF3 OA) in Older Adults Over 2 RSV Seasons." Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, vol. 78, no. 6, 2024, p. 1732, https://doi.org/10.1093/cid/ciae010.